Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clarridge, J. E. Articles by Zhang, Q. Search for Related Content PubMed PubMed Citation Articles by Clarridge, J. E., III Articles by Zhang, Q.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2002, p. 3442-3448, Vol. 40, No. 9
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.9.3442-3448.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Genotypic Diversity of Clinical Actinomyces Species: Phenotype, Source, and Disease Correlation among Genospecies

Jill E. Clarridge III^1,2,3* and Qing Zhang¹

Department of Pathology,¹ Department of Molecular Virology and Microbiology, Baylor College of Medicine,² Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Houston, Texas³

Received 28 March 2002/ Returned for modification 25 May 2002/ Accepted 8 June 2002

Top Abstract Introduction Materials and Methods Results Discussion References

 
We determined the frequency distribution of Actinomyces spp. recovered in a routine clinical laboratory and investigated the clinical significance of accurate identification to the species level. We identified 92 clinical strains of Actinomyces, including 13 strains in the related Arcanobacterium-Actinobaculum taxon, by 16S rRNA gene sequence analysis and recorded their biotypes, sources, and disease associations. The clinical isolates clustered into 21 genogroups. Twelve genogroups (74 strains) correlated with a known species, and nine genogroups (17 strains) did not. The individual species had source and disease correlates. Actinomyces turicensis was the most frequently isolated species and was associated with genitourinary tract specimens, often with other organisms and rarely with inflammatory cells. Actinomyces radingae was most often associated with serious, chronic soft tissue abscesses of the breast, chest, and back. Actinomyces europaeus was associated with skin abscesses of the neck and genital areas. Actinomyces lingnae, Actinomyces gravenitzii, Actinomyces odontolyticus, and Actinomyces meyeri were isolated from respiratory specimens, while A. odontolyticus-like strains were isolated from diverse sources. Several of the species were commonly coisolated with a particular bacterium: Actinomyces israelii was the only Actinomyces spp. coisolated with Actinobacillus (Haemophilus) actinomycetemcomitans; Actinomyces meyeri was coisolated with Peptostreptococcus micros and was the only species other than A. israelii associated with sulfur granules in histological specimens. Most genogroups had consistent biotypes (as determined with the RapID ANA II system); however, strains were misidentified, and many codes were not in the database. One biotype was common to several genogroups, with all of these isolates being identified as A. meyeri. Despite the recent description of new Actinomyces spp., 19% of the isolates recovered in our routine laboratory belonged to novel genospecies. One novel group with three strains, Actinomyces houstonensis sp. nov., was phenotypically similar to A. meyeri and A. turicensis but was genotypically closest to Actinomyces neuii. A. houstonensis sp. nov. was associated with abscesses. Our data documented consistent site and disease associations for 21 genogroups of Actinomyces spp. that provide greater insights into appropriate treatments. However, we also demonstrated a complexity within the Actinomyces genus that compromises the biochemical identification of Actinomyces that can be performed in most clinical laboratories. It is our hope that this large group of well-defined strains will be used to find a simple and accurate biochemical test for differentiation of the species in routine laboratories.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Microbiological identification of Actinomyces to the species level is difficult in the clinical laboratory. Even with biochemical tests such as the RapID ANA II test, whole-cell fatty acid analysis, or gas-liquid chromatography, assignment to a species is difficult (1, 2, 3, 5, 8, 13). Thus, based only on Gram staining, the catalase reaction, and better growth under anaerobic conditions than aerobic conditions, strains may be assigned to the genus Actinomyces. An excellent paper addressing this problem and seeking an easily accessible scheme for reliable differentiation at the species level has recently been published (13).

It is not clear that assignment to a species is clinically important, although there have been some excellent previous reports of the frequencies of occurrence and site associations of Actinomyces species (4, 5, 7, 9, 12, 13, 14). Actinomyces neuii has been associated with abscesses; Actinomyces naeslundii has been reported to cause hip prosthesis infection (5); and in recent studies of three newly described species, Actinomyces turicensis was reported to be associated with genital, skin-related, and urinary tract infections, whereas Actinomyces radingae was found only in skin-related infections and Actinomyces europaeus was detected in patients with urinary tract infections (12, 13, 14). Hall et al. (6) examined a large collection of organisms and found that Actinomyces israelii and A. turicensis were most prevalent and were most commonly associated with intrauterine contraceptive devices. In textbooks, A. israelii is usually identified as the cause of actinomycosis, with other Actinomyces cited as causative agents in various unspecified diseases (11) and as normal flora.

However, when the species are distinguished, the data from different institutions show variations in species distributions and clinical associations. Sometimes this is because of the type of laboratory (public health, reference, or oral microbiology laboratory) or because of the relative proportion of isolates examined that are strict anaerobes (7, 13). Thus, the frequency of occurrence of Actinomyces spp. in a routine clinical laboratory and their clinical significance are largely unknown. In the study described in this paper we characterized by genotypic and phenotypic methods a large group of presumptively significant isolates that were isolated in the routine laboratory but not as strict anaerobes. We also reviewed patient data. We thus wished to determine the frequency of occurrence and association with disease of the aerotolerant Actinomyces spp. isolated in a clinical laboratory which were accurately identified by 16S ribosomal DNA (rDNA) sequence analysis.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Organisms. We sequenced 100 presumptively clinically significant strains of putative Actinomyces spp. that were recovered in a routine clinical laboratory on Trypticase soy agar with sheep blood or Columbia colistin-nalidixic acid agar (BBL, Becton Dickinson, Cockeysville, Md.) by incubation at 35°C with CO₂ (7%) added but without the use of special anaerobic conditions. Of these strains, 15 strains were not in the Actinomyces cluster and were not further studied; most were in the Bifidobacterium and Gardnerella groups, with at least one strain each of the genera Streptococcus, Erysipelothrix, and Abiotrophia. Thirteen strains were in the related Arcanobacterium-Actinobaculum taxon and were included in the study. In addition, we identified by 16S rDNA sequence analysis six strains as Actinomyces spp. that were originally identified as Lactobacillus, Streptococcus, or coryneform organisms. Thus, we analyzed 91 strains: 82 strains were obtained from the Microbiology Laboratory of the Houston Veterans Affairs Medical Center (VAMC) and 9 strains were from other clinical laboratories and were referred to the Houston VAMC for identification. All strains were stored frozen at -70°C. During the periods when we were most alerted to this group of organisms, the noted occurrence was about 15 to 20 cases per year. When available, patient records were reviewed for the clinical significance of the isolates. We made the assumption of possible significance if the isolate had one of the follow features: (i) was cultured from a normally sterile site, (ii) was the predominant organism or a copredominant organism from a wound infection or abscess, (iii) was found from a urine specimen culture at >10⁴ CFU/ml with no more than one other isolate at >10⁴ CFU/ml, or (iv) was the predominant organism isolated from a purulent sputum specimen. A careful review of medical notes was used to confirm clinical significance. The presence of polymorphonuclear leukocytes (PMNs), the use of surgical drainage, and a record of antibiotic treatment were primary indications of clinical significance. Although gram-positive branching rods were frequently noted on the original Gram stain, at times what were later shown on review to be Actinomyces were interpreted as gram-positive cocci in short chains.

Biochemical identification. All strains were grown at 35 to 37°C on sheep blood agar plates (Remel, Lenexa, Kans., and BBL, Becton Dickinson) with CO₂ added. Presumptive phenotypic identification was performed by Gram staining, evaluation of the colony morphology, and catalase reaction. None of the isolates was a strict anaerobe; all grew in an atmosphere with elevated CO₂ concentrations (5 to 8%). Biochemical testing was performed with RapID ANA II identification kits (RapID ANA; Remel, Inc., Norcross, Ga.). The interpretation of tests was done according to the manufacturer's instructions.

16S rDNA sequence analysis. 16S rRNA gene sequence identification was performed at the Houston VAMC laboratory and MIDI Labs (Newark, Del.) with the MicroSeq 500 gene kit (Applied Biosystems, Foster City, Calif.) according to the specifications of the manufacturer. Approximately 500 bp in both the forward and the reverse senses was sequenced for each isolate. Test strain sequences were compared with sequences in both the MicroSeq and the GenBank 16S rRNA gene sequence databases. The MicroSeq database contains sequences from 1,297 different species (1,187 type strains), including 9 type strains from the genus Actinomyces. Sequence data obtained from the strains in GenBank were included in the analysis. Sequences were compared in dendrogram form by using the neighbor-joining method (J. E. Clarridge, Q. Zhang, and S. Heward, Abstr. 101st Gen. Meet. Am. Soc. Microbiol., abstr., C-42, p. 157, 2001).

Nucleotide sequence accession numbers. The partial 16S rDNA sequence of the type strain of A. houstonensis Houston VAMC 3971 is deposited in GenBank under accession no. AF457638. To help compare isolates, we are depositing in GenBank one 500-bp sequence from each of the genospecies 2, 6, 13, and 17 (strains VAMC Ref113, VAMC 3971, VAMC Ref103, and S3672, respectively) as AF457642, AF457638, AF457641, and AF457640, respectively.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Genotypic identification and phylogenetic relationships. The dendrogram (Fig. 1) based on gene sequencing shows the overall relatedness of the Actinomyces spp. We show the type strains of 21 Actinomyces spp. and 4 related type strains (11 from the MicroSeq database, 13 from the GenBank database, and a challenge strain from the College of American Pathologists [CAP]) and representative clinical strains for each of the major groups. To present the sequences in a single comparative dendrogram, three or more clinical isolates that differed by no more than 5 bp are represented by a single entry. We note the number of isolates in the group; e.g., in genospecies 5 (A. europaeus), there are seven clinical strains. Because the Actinomyces odontolyticus-Actinomyces meyeri group was so diverse, the isolates are presented individually in Fig. 2.

View larger version (37K): [in this window] [in a new window]

FIG. 1. Dendrogram showing the genospecies (GS) clusters based on our sequence data for clinical isolates and some Actinomyces type strains from MicroSeq and GenBank databases with Bifidobacterium boum as an outgroup. All type strains are represented by the name written out in full. We note the type strain sequences from GenBank by GB and the number of base pairs that were used or available for comparison. The single strain from CAP has the suffix CAP, and the strains from the MicroSeq database do not have a suffix.

View larger version (43K): [in this window] [in a new window]

FIG. 2. Dendrogram showing the genospecies clusters based on our sequence data for clinical isolates within the A. odontolyticus-A. meyeri branch. In addition to all 14 clinical strains and the A. meyeri type strain, we show one A. odontolyticus type strain and two other sequences that were called A. odontolyticus in GenBank but which have 16S rDNA sequences different from that of the A. odontolyticus type strain. A. turicensis is the outgroup.

The 91 strains were clustered into 18 major genogroups and 3 minor genogroups (Fig. 1 and Fig. 2). Table 1 shows the distribution of species by the number of isolates in each genogroup, designated as in the dendrogram in Fig. 1. Table 2 shows the same type of data for the A. meyeri-A. odontotyticus groups, as shown in Fig. 2, except that the data are presented separately for each strain of this diverse group. Twelve genogroups correlated with a known species: A. turicensis (23 strains), A. radingae (13 strains), A. europaeus (7 strains), A. lingnae (4 strains), Actinomyces graevenitzii (4 strains), A. neuii (3 strains), A. odontolyticus (4 strains) A. meyeri (3 strains), A. israelii (3 strains), Arcanobacterium haemolyticum (9 strains), and 1 strain each of Actinomyces funkii and Arcanobacterium bernardiae. These are so designated in both Tables 1 and 2. Nine genogroups (17 strains; 19%) did not correlate closely with a known type strain. For these, the closest strain with at least 95% similarity is listed and the genogroup is called "novel." The most common sources and associated diseases are listed.

View this table: [in this window] [in a new window]

TABLE 1. Characteristics of the genogroups of clinically isolated Actinomyces strains

View this table: [in this window] [in a new window]

TABLE 2. Characteristics of genogroups 17 and 18, A. odontolyticus, and A. meyeri strains

Phenotypic characterization. The biochemical reactions obtained with the RapID ANA II system, coded as a biotype number, for the species sequenced are also presented in Tables 1 and 2. Although the biochemical identifications with this system frequently indicate an inaccurate species name (as indicated in the tables), many of the different genogroups show distinctive and reproducible biochemical profiles. For example, 4 A. europaeus strains had similar code numbers (421670, 421671, and 421070), 2 isolates of genogroup 10 generated similar codes (671671 and 671470), 18 of the 21 A. turicensis strains tested generated the same code (020671), and most of the A. radingae isolates generated a code similar to 677671 (Table 1). The same may be true for other genogroups, but due to the limited number of isolates in these other groups, we do not believe that the data are sufficiently robust for reliable identification.

The full description of the biochemical significance of the biotype numbers is presented in the literature accompanying the RapID ANA II system. Briefly, to summarize some important differences found in this study: most isolates shared the last three digits of 671 in their profile numbers, which indicates positive reactions for the cleavage of leucyl-glycine, glycine, proline, phenylalanine, arginine, and serine and negative reactions for alkaline phosphate, pyrrolidine, and indole. A. turicensis was usually additionally positive only for hydrolysis of aryl-substituted -glucoside. A. europaeus was positive for carbohydrate hydrolysis of aryl-substituted arabinoside, -glucoside, and galactoside. Genogroup 10 was additionally positive for ß-disaccharide, o-nitrophenyl-ß-D-galactopyranoside, and ß-glucoside. It is clear that, according to the RapID ANA II system database, many genospecies would be identified as A. meyeri (e.g., genospecies 2, 6, and 15). All strains except A. neuii and genospecies 9 were negative for catalase; A. neuii has previously been reported to be positive for catalase, and genospecies 9, a strain from gallbladder fluid with an unusual biotype profile, which we report here for the first time, was positive for catalase. Genospecies 9 and 10 cluster with the Actinomyces viscosus and A. naeslundii groups, which are variable for catalase (10). Most isolates in the A. odontolyticus clusters were identified as either A. odontolyticus or A. meyeri by the RapID ANA II system.

Sources and disease associations. Table 3 summarizes the sources and disease associations of the more common Actinomyces species and genospecies. A. turicensis was the most frequently isolated species and was associated with genitourinary tract specimens, often with other organisms and only rarely with inflammatory cells. In a few instances A. turicensis was isolated as a pure culture: from two urine specimens, one specimen from a wound, and one specimen from a breast abscess. It was the only Actinomyces sp. isolated from urine and urethral exudates. A. radingae was usually associated with abscesses; almost all of these were serious, chronic soft tissue abscesses of the breast, chest, and back. A. radingae was often recovered in large numbers and was usually associated with PMNs. A. europaeus was associated with soft tissue abscesses of the neck and genital areas. The newly described species A. lingnae was found in low numbers in respiratory specimens from compromised hosts.

View this table: [in this window] [in a new window]

TABLE 3. Site of isolation or infection associated with Actinomyes spp. for which there were at least three strains

Both A. israelii and A. meyeri were associated with pulmonary actinomycosis and sulfur granules in histological specimens. A. israelii was the only Actinomyces sp. coisolated with Actinobacillus (Haemophilus) actinomycetemcomitans. A. meyeri was coisolated with Peptostreptococcus micros. Because these two coisolates are well-known pathogens in their own right, it is interesting to speculate on their contribution to disease.

In Table 4 we present our deductions of the normal niches of the various Actinomyces spp. by correlating both the site of isolation (indicated in Tables 2, 3, and 4) and the known niche of the common coisolates. A. radingae and A. europaeus were isolated with low numbers of coagulase-negative Staphylococcus spp. and Corynebacterium spp., suggesting skin contamination and that the niche for these organisms is the skin. A. lingnae, A. graevenitzii, A. odontolyticus, A. meyeri, and genospecies 10 are associated with respiratory specimens. The two strains in genospecies 10 were cultured from a mandible and a face, and their sequences had 98% similarity to an unnamed oral clone of Actinomyces sp. from GenBank (accession no. AF287749). Streptococcus intermedius and Eikenella corrodens were also found in these cultures, further suggesting an oral source. The A. odontolyticus-like strains (genospecies 17a to 17c) were isolated from heterogeneous sources, some of which suggest hematogenous spread and a genitourinary or gastrointestinal source.

View this table: [in this window] [in a new window]

TABLE 4. Discovery of the probable normal niche of Actinomyces spp. approached by using the known niche of specific coisolates and the sources of the Actinomyces strains in this investigationa

In both instances in which two different Actinomyces spp. were recovered in the same specimen, the presumed niches agreed: the respiratory site-associated species, A. graevenitzii and A. lingnae, were recovered together, both in low numbers, from bronchial wash specimens; and the skin- and abscess-associated species, A. europaeus and A. radingae, were recovered together from a back abscess.

Two genetically well-separated genospecies, genospecies 6 and 13, had multiple strains. Below we describe genospecies 6 as A. houstonensis sp. nov.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Using 16S rRNA gene sequencing to identify clinically derived Actinomyces spp., we determined the frequency distributions of species isolated in a single laboratory and their site and disease associations. As in some other studies, A. turicensis was the most commonly isolated species (7, 12). However, A. radingae and A. europaeus were the second and third most frequently isolated species, respectively, in contrast to A. israelii and A. naeslundii, respectively, in the study by Hall et al. (7). Sabbe et al. (12) found twice as many A. europaeus isolates as A. radingae isolates.

A. turicensis was most commonly associated with the urinary tract infections and skin-related infections of the lower body. In contrast to Funke et al. (5), some of the A. turicensis strains were isolated as pure cultures, and several caused abscesses. A. radingae and A. europaeus were associated with soft tissue infections. Our data show a striking correlation of A. radingae with recurrent abscesses of the chest, back, and breast. Infections due to A. europaeus were also found in the genital area, such as scrotal abscesses and labia abscesses. A. meyeri and A. israelii were both associated with actinomycosis, sulfur granules, and a distinct coisolate.

The RapID ANA II system biochemical tests for A. turicensis, A. radingae, and A. europaeus were reproducible, yielding codes that were useful for identification; however, the code numbers either corresponded to another organism or were not in the database. The same biotype for A. turicensis was noted by Sabbe et al. (12). Our data confirm the revised description by Vandamme et al. (14) that A. radingae strains are positive for N-acetylglucosamine and ß-glucosidase, while A. turicensis strains are negative. Our biochemical data do not support the identification scheme proposed by Sarkonen et al. (13), who used reagents from a different manufacturer.

In contrast to biochemical identification, which, as we have shown here, might be ambiguous, 16S rRNA sequence analysis assigns an unknown strain to a reproducible genocluster. Because we sequenced all isolates in a cluster, we were able to discern that some genogroups are more heterogeneous than others. For example, organisms in the A. graevenitzii and A. viscosus-A. naeslundii clusters were genetically heterogeneous, as was also determined from the data of Hall et al. (7). The heterogeneity in the A. odontolyticus-like groups allowed us to distinguish one group that seemed to have a gastrointestinal source. In contrast, genogroups that showed minimal variations in their 16S rDNA sequences and that were closely related to the type strain are A. turicensis, A. radingae, A. europaeus, and the newly described species A. lingnae.

Nine genogroups did not have a corresponding known type strain at the time of submission of the manuscript. However, as many new sequences are being deposited and new species are being described every day, it is probable that other investigators will find similar strains.

At present, clinical microbiologists and infectious disease specialists should be cautious in their acceptance of an identification as an Actinomyces species by testing that is usually performed in most clinical laboratories. Case reports based on identifications achieved prior to the use of 16S rDNA-based techniques (2, 6, 7, 9, 10) may not be accurate. Our data document consistent site and disease associations for 21 genogroups of Actinomyces spp. that provide greater insights into the clinical relevance of the genogroups. However, we also demonstrate a complexity within the genus Actinomyces that compromises the biochemical identification of Actinomyces that can be performed in most clinical laboratories. It is our hope that this large group of well-defined strains will be used to find simple and accurate biochemical tests for differentiation of the species in routine laboratories.

Description of Actinomyces houstonensis sp. nov. Actinomyces means ray fungus for the shape of the microcolonies; houstonensis, in honor of Houston, Texas, indicates the place where the bacterium was identified and described.

A. houstonensis is facultatively anaerobic and grows on sheep blood agar as -hemolytic, gray colonies 0.2 mm in diameter after 48 h of incubation at 36°C with elevated CO₂ concentrations (8%). Growth is equal with elevated CO₂ and anaerobic conditions. By Gram stain, the cells are nonsporulating, gram-positive pleomorphic rods, which are more robust than those of A. meyeri, and have a tendency to form half circles. The organism is nonmotile and catalase negative. It is esculin, urease, and gelatin test negative. It reduces nitrate and produces positive reactions for the cleavage of aryl-substituted -glucoside, leucyl-glycine, glycine, proline, phenylalanine, arginine, and serine and negative reactions for alkaline phosphate, pyrrolidine, and indole. It ferments glucose and sucrose but not xylose. The type strain was isolated from an abscess from the back of a patient. All three strains were associated with serious subcutaneous abscesses requiring drainage; two strains were associated with other organisms that tend to be associated with the gastrointestinal tract or skin. The type strain of A. houstonensis is Houston VAMC strain 3971 and is deposited in GenBank under accession no. AF457638.

 
* Corresponding author. Present address: VA Puget Sound Health Care System, Seattle, WA 98102. Phone: (206) 277-4514. Fax: (206) 764-2001. E-mail: jill.clarridge{at}med.va.gov.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Brander, M. A., and H. R. Jousimies-Somer. 1992. Evaluation of the RapID ANA II and API ZYM systems for identification of Actinomyces species from clinical specimens. J. Clin. Microbiol. 30:3112-3116.[Abstract/Free Full Text]
2
2. Collins, M. D., L. Hoyles, S. Kalfas, G. Sundquist, T. Monsen, N. Nikolaitchouk, and E. Falsen. 2000. Characterization of Actinomyces isolates from infected root canals of teeth: description of Actinomyces radicidentis sp. nov. J. Clin. Microbiol. 38:3399-3403.[Abstract/Free Full Text]
3
3. Funke, G. 1999. Algorithm for identification of aerobic gram-positive rods, p. 316-318. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
4
4. Funke, G., N. Alvarez, C. Pascual, E. Falsen, E. Akervall, L. Sabbe, L. Schouls, N. Weiss, and M. D. Collins. 1997. Actinomyces europaeus sp. nov., isolated from human clinical specimens. Int. J. Syst. Bacteriol. 47:687.[Abstract/Free Full Text]
5
5. Funke, G., A. von Graevenitz, J. E. Clarridge III, and K. E. Bernard. 1997. Clinical microbiology of coryneform bacteria. Clin. Microbiol. Rev. 10:125-159.[Abstract/Free Full Text]
6
6. Hall, V., G. L. O'Neill, J. T. Magee, and B. I. Duerden. 1999. Development of amplified 16S ribosomal DNA restriction analysis for identification of Actinomyces species and comparison with pyrolysis-mass spectrometry and conventional biochemical tests. J. Clin. Microbiol. 37:2255-2261.[Abstract/Free Full Text]
7
7. Hall, V., P. R. Talbot, S. L. Stubbs, and B. I. Duerden. 2001. Identification of clinical isolates of Actinomyces species by amplified 16S ribosomal DNA restriction analysis. J. Clin. Microbiol. 39:3555-3562.[Abstract/Free Full Text]
8
8. Miller, P. H., L. S. Wiggs, and J. M. Miller. 1995. Evaluation of API An-IDENT and RapID ANA II systems for identification of Actinomyces species from clinical specimens. J. Clin. Microbiol. 33:329-330.[Abstract/Free Full Text]
9
9. Pascual, C., G. Foster, E. Falsen, K. Bergstrom, C. Greko, and M. D. Collins. 1999. Actinomyces bowdenii sp. nov., isolated from canine and feline clinical specimens. Int. J. Syst. Bacteriol. 49:1873-1877.[Abstract/Free Full Text]
10
10. Ramos, C. P., G. Foster, and M. D. Collins. 1997. Phylogenetic analysis of the genus Actinomyces based on 16S rRNA gene sequences: description of Arcanobacterium phocae sp. nov., Arcanobacterium bernardiae comb. nov., and Arcanobacterium pyogenes comb. nov. Int. J. Syst. Bacteriol. 47:46-53.[Abstract/Free Full Text]
11
11. Rodloff, A. C., S. H. Hillier, and B. J. Moncla. 1999. Peptostreptococcus, Propionibacterium, Lactobacillus, Actinomyces, and other non-spore-forming anaerobic gram-positive rods, p. 672-689. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
12
12. Sabbe, L. J. M., D. Van de Merwe, L. Schouls, A. Bergmans, M. Vaneechoutte, and P. Vandamme. 1999. Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus. J. Clin. Microbiol. 37:8-13.[Abstract/Free Full Text]
13
13. Sarkonen, N., E. Kononen, P. Summanen, M. Kononen, and H. Jousimies-Somer. 2001. Phenotypic identification of Actinomyces and related species isolated from human sources. J. Clin. Microbiol. 39:3955-3961.[Abstract/Free Full Text]
14
14. Vandamme, P., E. Falsen, M. Vancanneyt, et al. 1998. Characterization of A. turicensis and A. radingae strains from human clinical samples. Int. J. Syst. Bacteriol. 48:503-510.[Abstract/Free Full Text]

---

Journal of Clinical Microbiology, September 2002, p. 3442-3448, Vol. 40, No. 9
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.9.3442-3448.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Renvoise, A., Raoult, D., Roux, V. (2009). Actinomyces massiliensis sp. nov., isolated from a patient blood culture. Int. J. Syst. Evol. Microbiol. 59: 540-544 [Abstract] [Full Text]  
• Watkins, R. R., Anthony, K., Schroder, S., Hall, G. S. (2008). Ventriculoperitoneal Shunt Infection Caused by Actinomyces neuii subsp. neuii. J. Clin. Microbiol. 46: 1888-1889 [Abstract] [Full Text]  
• Lely, R. J., van Es, H. W. (2005). Case 85: Pelvic Actinomycosis in Association with an Intrauterine Device. Radiology 236: 492-494 [Full Text]  
• Clarridge, J. E. III (2004). Impact of 16S rRNA Gene Sequence Analysis for Identification of Bacteria on Clinical Microbiology and Infectious Diseases. Clin. Microbiol. Rev. 17: 840-862 [Abstract] [Full Text]  
• Santala, A.-M., Sarkonen, N., Hall, V., Carlson, P., Jousimies-Somer, H., Kononen, E. (2004). Evaluation of Four Commercial Test Systems for Identification of Actinomyces and Some Closely Related Species. J. Clin. Microbiol. 42: 418-420 [Abstract] [Full Text]  
• Sixou, J.-L., Magaud, C., Jolivet-Gougeon, A., Cormier, M., Bonnaure-Mallet, M. (2003). Evaluation of the Mandibular Third Molar Pericoronitis Flora and Its Susceptibility to Different Antibiotics Prescribed in France. J. Clin. Microbiol. 41: 5794-5797 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clarridge, J. E. Articles by Zhang, Q. Search for Related Content PubMed PubMed Citation Articles by Clarridge, J. E., III Articles by Zhang, Q.